Shares are up 51% as of this post on only 2,000 trades and almost a million in volume $1.22 [mstock id="73007" asset="hils"] Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments https://www.globenewswire.com/news-release/2022/06/27/2469512/0/en/Hillstream-BioPharma-Announces-Collaboration-with-Sapien-Biosciences-in-Cancer-Treatments.html BRIDGEWATER, N.J., June 27, 2022 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (Hillstream or the Company), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, today announced a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.Immune Checkpoint Inhibitors and Ferroptosis